Clinical Trial Update: Study of NEROFE, a Novel Hormone-Peptide in Adult Patients With Advanced MDS and AML [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for NEROFE, a novel hormone-peptide, in adults with advanced myelodysplastic syndrome and acute myeloid leukemia; the study is cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• NEROFE

Snippet

Sponsor: Immune System Key Ltd | Conditions: Advanced MDS, AML | Phase 1 | Status: RECRUITING